In view of the results of the enrichment analysis, we found that the liver cancer signaling pathways impacted by treatment with BSJPD mostly involved tumor apoptosis and growth, such as the PI3K-Akt-mTOR, p53, TNF, and VEGF pathways [7, 8]. The gene discussed is AKT1; the disease is liver cancer.